Fexofenadine Dosing for Hives (Urticaria)
For adults and children ≥12 years with chronic urticaria, start with fexofenadine 60 mg twice daily or 180 mg once daily, and if symptoms remain uncontrolled after 2-4 weeks, increase the dose up to 4-fold (240 mg twice daily or 720 mg once daily). 1, 2
Standard Dosing by Age
Adults and Children ≥12 Years
- Initial dose: 60 mg twice daily OR 180 mg once daily 1
- Both regimens are FDA-approved and equally effective
- Take with water
Children 6-11 Years
- Dose: 30 mg twice daily 1
- Based on pharmacokinetic modeling showing this produces comparable exposures to adult dosing 3
Children 6 months to 5 years
- Dose: 15 mg twice daily for children ≤10.5 kg; 30 mg twice daily for children >10.5 kg 3, 4
- Well-tolerated safety profile established in clinical trials 4
Dose Escalation Algorithm
The 2022 international urticaria guidelines provide clear direction on stepping up therapy 2:
Start: Standard-dose second-generation antihistamine (fexofenadine 60 mg BID or 180 mg daily)
After 2-4 weeks (or earlier if symptoms intolerable):
- If inadequate control → Increase dose up to 4-fold
- For fexofenadine: up to 240 mg twice daily or 720 mg once daily
- This updosing is supported by Grade A evidence for fexofenadine 5
If still inadequate control: Add omalizumab (not further antihistamine increase)
When stepping down:
- Only after ≥3 consecutive months of complete control
- Reduce by maximum 1 tablet per month
- If breakthrough symptoms occur, return to last effective dose 2
Key Clinical Considerations
Efficacy timeline: Fexofenadine provides rapid symptom relief, with significant improvement typically seen within the first week of treatment 6, 7, 8. By 4 weeks at standard dosing, 42% of patients achieve complete symptom resolution 8.
Updosing safety: Fexofenadine can be safely increased to 3-4 times the standard dose without dose-dependent adverse effects or cardiotoxicity 5. Unlike cetirizine, fexofenadine does not show increased sedation at higher doses 5.
Renal impairment: Start with 60 mg once daily (adults) or 30 mg once daily (children 6-11 years) in patients with decreased renal function 1.
Common pitfall: Many physicians hesitate to updose antihistamines and instead add a second antihistamine or immunomodulator prematurely. The evidence clearly supports updosing a single second-generation antihistamine before adding other agents 2, 5.
Pregnancy: While best avoided in first trimester, fexofenadine has no evidence of teratogenicity. Loratadine and cetirizine are FDA Pregnancy Category B if antihistamine therapy is necessary 9.